U.S. Pharmacist

e-Pharm/alert: Now available! A new prescription eye drop for dry eye disease

U.S. Pharmacist sent this email to their subscribers on December 15, 2023.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Forward to a friend

 

 

 3 Pharmlert e-Pharmalert Providing important information to healthcara professionals since 1976
NOW AVAILABLE Miebor perfluorohexyloctane ophthalimic solution The first and only prescription eye drop for dry eye disease that directly targets evaporation Miecbo: uscheyi s
See how MIEBO works
Order Now
Cardinal Health: 5858964
McKesson: 2841351
AmerisourceBergen: 10281423
Product information1
•  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  
Product trade name: MIEBO
Delivery: Topical ophthalmic solution
Active ingredient: Perfluorohexyloctane 100%
Inactive ingredients: None
Preservatives: None
How supplied: Polypropylene bottles with dropper tips and screw caps in the following size: 3-mL fill in a 5-mL container
Indication and usage: MIEBO is a semifluorinated alkane indicated for the treatment of the signs and symptoms of dry eye disease
The chemical structure is:
Fill size: 3 mL
No A/B generic equivalent available
IMPORTANT SAFETY INFORMATION
MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
Please see additional Important Safety Information below.
Learn more about MIEBO
Savings offers are available for patients.
Explore copay savings
IMPORTANT SAFETY INFORMATION (cont’d)
Instruct patients to instill one drop of MIEBO into each eye four times daily
The safety and efficacy in pediatric patients below the age of 18 have not been established
The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
Reference: 1. MIEBO. Prescribing Information. Bausch & Lomb, Inc; 2023.
BAUSCHLOMB
© 2023 Bausch + Lomb MBO.0510.USA.23
Bausch + Lomb Eye Care Rx
1400 N. Goodman Street | Rochester, New York 14609
Please do not reply to this email. If you have questions related to our products, contact our Customer Care at: (800)-553-5340.
 |  | LEGAL NOTICE

Text-only version of this email

                                                  Forward to a friend 3 Pharmlert e-Pharmalert Providing important information to healthcara professionals since 1976 NOW AVAILABLE Miebor perfluorohexyloctane ophthalimic solution The first and only prescription eye drop for dry eye disease that directly targets evaporation Miecbo: uscheyi s See how MIEBO works Order Now Cardinal Health: 5858964 McKesson: 2841351 AmerisourceBergen: 10281423 Product information1 •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •  •   Product trade name: MIEBO Delivery: Topical ophthalmic solution Active ingredient: Perfluorohexyloctane 100% Inactive ingredients: None Preservatives: None How supplied: Polypropylene bottles with dropper tips and screw caps in the following size: 3-mL fill in a 5-mL container Indication and usage: MIEBO is a semifluorinated alkane indicated for the treatment of the signs and symptoms of dry eye disease The chemical structure is: Fill size: 3 mL No A/B generic equivalent available IMPORTANT SAFETY INFORMATION • MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO Please see additional Important Safety Information below. Learn more about MIEBO Savings offers are available for patients. Explore copay savings IMPORTANT SAFETY INFORMATION (cont’d) • Instruct patients to instill one drop of MIEBO into each eye four times daily • The safety and efficacy in pediatric patients below the age of 18 have not been established • The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness) You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Click here for full Prescribing Information for MIEBO. Reference: 1. MIEBO. Prescribing Information. Bausch & Lomb, Inc; 2023. BAUSCHLOMB © 2023 Bausch + Lomb MBO.0510.USA.23 Bausch + Lomb Eye Care Rx 1400 N. Goodman Street | Rochester, New York 14609 Please do not reply to this email. If you have questions related to our products, contact our Customer Care at: (800)-553-5340.  |  | LEGAL NOTICE
Show all

The Latest Emails Sent By U.S. Pharmacist

More Emails, Deals & Coupons From U.S. Pharmacist

Email Offers, Discounts & Promos From Our Top Stores